Science & Policy
Vitamin C linked to fewer deaths in blood disorder trial
Summary: Vitamin C may do more than support the immune system.
Key points
- Vitamin C may do more than support the immune system.
- In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications.
- An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo.
Vitamin C may do more than support the immune system. In a phase 2 trial of people with precancerous or low risk blood cancers, daily vitamin C did not slow abnormal cell growth, but it was linked to favorable changes in inflammation and fewer serious complications. An exploratory follow up also found fewer deaths among participants taking vitamin C than among those receiving placebo.
Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.